Vibe Bio

www.vibebio.com

Vibe Bio invests in founders committed to finding cures for rare and overlooked diseases. The venture fund is dedicated to empowering visionary founders developing platform technologies and therapeutics, especially those targeting rare or overlooked diseases, regardless of modality or disease area.

Check Size

Not specified

Stages

Seed, Series A, Series B

Focus Areas

Biotech, Ai Ml, Healthtech

Is Vibe Bio right for your startup?

Upload your pitch deck and get an AI-powered match score in minutes. See exactly how well you fit their investment criteria.

See If You're a Match

Investment Thesis

Vibe Bio operates at the intersection of AI-driven insights and therapeutic development, believing that groundbreaking cures shouldn’t be sidelined due to funding gaps or analytical limitations. They employ their proprietary VibeOne AI platform to conduct rigorous due diligence, assess risk, benchmark against competitors, and plan strategically—both for their own investment decisions and to guide their portfolio companies. The firm combines AI-enhanced decision-making with a mission-driven approach focused on patient impact.

What Sets Them Apart

Proprietary VibeOne AI platform that conducts AI-driven assessment of drug program potential, providing portfolio companies with competitive advantages beyond capital
Dual business model combining venture capital with an AI analytics software platform (VibeOne) used for BD/licensing decisions
Focus on rare and overlooked diseases, addressing market gaps underserved by traditional pharma
AI-powered due diligence provides 8x faster asset diligence, 75% SME workload reduction, and 50% more assets identified globally
Support system extending beyond funding: network access, strategic insights, and operational support for portfolio companies
Multi-language capability evaluating 40+ languages to identify global assets from China, Japan, Korea, and other countries